217 related articles for article (PubMed ID: 28333708)
21. Screening for proteinuria in US adults: a cost-effectiveness analysis.
Boulware LE; Jaar BG; Tarver-Carr ME; Brancati FL; Powe NR
JAMA; 2003 Dec; 290(23):3101-14. PubMed ID: 14679273
[TBL] [Abstract][Full Text] [Related]
22. Gaps in antihypertensive and statin treatments and benefits of optimisation: a modelling study in a 1 million ethnically diverse urban population in UK.
Wu R; Rison SCG; Raisi-Estabragh Z; Dostal I; Carvalho C; Robson J; Mihaylova B
BMJ Open; 2021 Dec; 11(12):e052884. PubMed ID: 35536740
[TBL] [Abstract][Full Text] [Related]
23. Racial Differences in Plasma Levels of N-Terminal Pro-B-Type Natriuretic Peptide and Outcomes: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.
Bajaj NS; Gutiérrez OM; Arora G; Judd SE; Patel N; Bennett A; Prabhu SD; Howard G; Howard VJ; Cushman M; Arora P
JAMA Cardiol; 2018 Jan; 3(1):11-17. PubMed ID: 29167879
[TBL] [Abstract][Full Text] [Related]
24. Antihypertensive medication use in Hispanic adults: a comparison with black adults and white adults.
Sudano JJ; Baker DW
Med Care; 2001 Jun; 39(6):575-87. PubMed ID: 11414262
[TBL] [Abstract][Full Text] [Related]
25. Population-Attributable Risk for Cardiovascular Disease Associated With Hypertension in Black Adults.
Clark D; Colantonio LD; Min YI; Hall ME; Zhao H; Mentz RJ; Shimbo D; Ogedegbe G; Howard G; Levitan EB; Jones DW; Correa A; Muntner P
JAMA Cardiol; 2019 Dec; 4(12):1194-1202. PubMed ID: 31642869
[TBL] [Abstract][Full Text] [Related]
26. Racial Differences in Blood Pressure Control Following Stroke: The REGARDS Study.
Akinyelure OP; Jaeger BC; Moore TL; Hubbard D; Oparil S; Howard VJ; Howard G; Buie JN; Magwood GS; Adams RJ; Bonilha L; Lackland DT; Muntner P
Stroke; 2021 Dec; 52(12):3944-3952. PubMed ID: 34470498
[TBL] [Abstract][Full Text] [Related]
27. Cost-Effectiveness of Initiating Pharmacological Treatment in Stage One Hypertension Based on 10-Year Cardiovascular Disease Risk: A Markov Modeling Study.
Constanti M; Floyd CN; Glover M; Boffa R; Wierzbicki AS; McManus RJ
Hypertension; 2021 Feb; 77(2):682-691. PubMed ID: 33342242
[TBL] [Abstract][Full Text] [Related]
28. Black-White Differences in 20-year Trends in Cardiovascular Risk in the United States, 1990-2010.
Mitchell UA; Ailshire JA; Kim JK; Crimmins EM
Ethn Dis; 2019; 29(4):587-598. PubMed ID: 31641326
[TBL] [Abstract][Full Text] [Related]
29. Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea.
Liew D; Park HJ; Ko SK
Clin Ther; 2009 Oct; 31(10):2189-203; discussion 2150-1. PubMed ID: 19922890
[TBL] [Abstract][Full Text] [Related]
30. Racial and Ethnic Differences in Antihypertensive Medication Use and Blood Pressure Control Among US Adults With Hypertension: The National Health and Nutrition Examination Survey, 2003 to 2012.
Gu A; Yue Y; Desai RP; Argulian E
Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28096206
[TBL] [Abstract][Full Text] [Related]
31. Cardiovascular disease risk factors and preventive practices among adults--United States, 1994: a behavioral risk factor atlas. Behavioral Risk Factor Surveillance System State Coordinators.
Hahn RA; Heath GW; Chang MH
MMWR CDC Surveill Summ; 1998 Dec; 47(5):35-69. PubMed ID: 9859955
[TBL] [Abstract][Full Text] [Related]
32. Association of duration of residence in the southeastern United States with chronic kidney disease may differ by race: the REasons for Geographic and Racial Differences in Stroke (REGARDS) cohort study.
Plantinga L; Howard VJ; Judd S; Muntner P; Tanner R; Rizk D; Lackland DT; Warnock DG; Howard G; McClellan WM
Int J Health Geogr; 2013 Mar; 12():17. PubMed ID: 23518004
[TBL] [Abstract][Full Text] [Related]
33. Estimated 10-year stroke risk by region and race in the United States: geographic and racial differences in stroke risk.
Cushman M; Cantrell RA; McClure LA; Howard G; Prineas RJ; Moy CS; Temple EM; Howard VJ
Ann Neurol; 2008 Nov; 64(5):507-13. PubMed ID: 19067365
[TBL] [Abstract][Full Text] [Related]
34. Incident ESRD and treatment-resistant hypertension: the reasons for geographic and racial differences in stroke (REGARDS) study.
Tanner RM; Calhoun DA; Bell EK; Bowling CB; Gutiérrez OM; Irvin MR; Lackland DT; Oparil S; McClellan W; Warnock DG; Muntner P
Am J Kidney Dis; 2014 May; 63(5):781-8. PubMed ID: 24388119
[TBL] [Abstract][Full Text] [Related]
35. Cost-Effectiveness of Antihypertensive Therapy in Patients Older Than 80 Years: Cohort Study and Markov Model.
Hazra NC; Rudisill C; Jackson SH; Gulliford MC
Value Health; 2019 Dec; 22(12):1362-1369. PubMed ID: 31806192
[TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness of vaccination against invasive pneumococcal disease among people 50 through 64 years of age: role of comorbid conditions and race.
Sisk JE; Whang W; Butler JC; Sneller VP; Whitney CG
Ann Intern Med; 2003 Jun; 138(12):960-8. PubMed ID: 12809452
[TBL] [Abstract][Full Text] [Related]
37. Risk Factors for Low Pharmacy Refill Adherence Among Older Hypertensive Men and Women by Race.
Williams LG; Peacock E; Joyce C; Bazzano LA; Sarpong D; Whelton PK; Holt EW; Re R; Frohlich E; He J; Muntner P; Krousel-Wood M
Am J Med Sci; 2018 Nov; 356(5):464-475. PubMed ID: 30384953
[TBL] [Abstract][Full Text] [Related]
38. Geographic and demographic variability in 20-year hypertension incidence: the CARDIA study.
Levine DA; Lewis CE; Williams OD; Safford MM; Liu K; Calhoun DA; Kim Y; Jacobs DR; Kiefe CI
Hypertension; 2011 Jan; 57(1):39-47. PubMed ID: 21135358
[TBL] [Abstract][Full Text] [Related]
39. Cost-effectiveness of Intensive Blood Pressure Management.
Richman IB; Fairley M; Jørgensen ME; Schuler A; Owens DK; Goldhaber-Fiebert JD
JAMA Cardiol; 2016 Nov; 1(8):872-879. PubMed ID: 27627731
[TBL] [Abstract][Full Text] [Related]
40. Hypertension severity, apparent treatment resistant hypertension and hyperuricemia in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
Tanner RM; Chaudary N; Colantonio LD; Merriman TR; Reynolds RJ; Bridges SL; Cushman M; Saag K; Limdi N; Muntner P; Howard G; Irvin MR
J Hypertens; 2023 Jun; 41(6):1033-1039. PubMed ID: 37016935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
